tiprankstipranks
Helus Pharma (HELP)
NASDAQ:HELP
US Market
HELP
Helus Pharma
RESEARCH TOOLSreports

Helus Pharma (HELP) Income Statement

2,500 Followers

Helus Pharma Income Statement

Last quarter (Q4 2026), Helus Pharma's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Helus Pharma's net income was C$-46.34M. See Helus Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Jun 25Mar 24Mar 23Mar 22
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -166.28KC$ -472.27K-C$ -251.01KC$ -167.76K
Operating Expenses
C$ 197.41MC$ 143.15MC$ 78.84MC$ 51.52MC$ 63.84M
Depreciation and Amortization
C$ 166.28KC$ 475.00KC$ 424.00KC$ 251.00KC$ 168.00K
EBITDA
C$ -197.41MC$ -142.67MC$ -78.41MC$ -51.27MC$ -63.67M
Operating Income
C$ -197.58MC$ -143.15MC$ -78.84MC$ -51.52MC$ -63.84M
Other Income/Expenses
C$ -7.50MC$ 30.01MC$ 756.00KC$ 4.03MC$ -3.79M
Pretax Income
C$ -205.08MC$ -113.14MC$ -78.08MC$ -47.49MC$ -67.63M
Net Income
C$ -205.08MC$ -113.14MC$ -78.08MC$ -47.49MC$ -67.63M
Per Share Metrics
Basic EPS
C$ -5.90C$ -5.59C$ -3.91C$ -9.73C$ -15.36
Diluted EPS
C$ -5.90C$ -5.59C$ -9.41C$ -9.74C$ -15.36
Weighted Average Shares Outstanding
 34.80M 20.22M 20.00M 4.88M 4.40M
Weighted Average Shares Outstanding (Diluted)
 34.80M 20.22M 20.00M 4.88M 4.40M
Currency in CAD

Helus Pharma Earnings and Revenue History